SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Guilford (GLFD) - Steadily Rising
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
496 22 0 GLFD
Emcee:  Jim Ball Type:  Unmoderated
Introduction Market Data Compact
GLFD has been steadily rising for about 18 months with no pullback. Low of about $5 in 1995 to high of $30 today. Up from about $19 over the last 3-4 weeks. I understand they are seeking FDA approval of a new Cancer treatment in June. Alex Brown recently recommended as a "Strong Buy". Might be one to put in the portfolio for a while.

Jim
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
496same here, cant help but think they are in the throes, but then again, I have semopgcw-4/8/2005
495Count me as one of the skeptics. They bought Aggrastat on the theory that Mercktuck-4/7/2005
494New strategies at Guilford Baltimore biotech Guilford Pharmaceuticals says it wmopgcw-4/7/2005
493Very sad, sad story..... so many well-meant and exciting shots on goal. GLFDscaram(o)uche-3/25/2005
492indeed it looks dire.mopgcw-3/24/2005
491Almost a worst case scenario for glfd given serious balance sheet problems. I asrkrw-3/24/2005
490Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary Endpmopgcw-3/24/2005
489Well, this explains the sudden move, hope it holds, I own some <i>12:01 Etom pope-9/14/2004
488Interesting article on the propofol market: tinyurl.comrkrw-7/14/2004
487NORDMANN RONALD M,Director,BUYS 20,000 ON 7/2/04 OF GLFD 2004-07-07 17:29 (New Ymopgcw-7/9/2004
486I think midazolam (versed) is generic but not 100% sure. You should try emailirkrw-6/18/2004
485Tuck: Some hints of what GLFD has in mind. 11/06/04 PR. Per study investigatofred hayes-6/18/2004
484>>BALTIMORE, June 18 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Intuck-6/18/2004
483>>I think glfd's commercial strategy is to go into markets where propotuck-6/18/2004
482Like Harry, I had knee arthrsocopy surgery last fall. I requested propofol. Fellrkrw-6/18/2004
481Inotek, a private company outside of Boston, seems (to me at least) to have the NeuroInvestment-6/17/2004
480Thanks, guys, that helps. Once again wondering if there's anything left . tuck-6/17/2004
479I agree.I have had two propofol anesthesias in the last few months (knee arthrosNeuroInvestment-6/17/2004
478Tuck big problem with aquavan is the propofol competition the original product dalroi-6/17/2004
477Stefaan, Do you or your colleagues have an opinion about Aquavan? Rick says rktuck-6/17/2004
476>>BALTIMORE, June 17 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Intuck-6/17/2004
475Zeta, rkrw and Rick both decided Aquavan would be a hard sell even if approved.tuck-5/12/2004
474Thanks Miljenko...I'm particularly interested because I worked many years inzeta1961-5/11/2004
473Aquavan is water soluble pro-drug of propofol. Improved pharmacokinetic should oMiljenko Zuanic-5/11/2004
472Miljenko, I listened to their CC for the first time today... I'm trying to zeta1961-5/10/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News